We are live on
!
Find out more
TCM
Tanaka Capital Management Portfolio holdings
AUM
$59.9M
This Fund
S&P 500
This Quarter
Est. Return
+19.61%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$54.8M
AUM Growth
-$711K
(-1.3%)
Cap. Flow
-$6.04M
Cap. Flow
% of AUM
-11.03%
Top 10 Holdings %
Top 10 Hldgs %
66.52%
Holding
44
New
–
Increased
2
Reduced
14
Closed
–
Top Buys
| 1 |
Nuvation Bio
NUVB
|
+$969K |
Top Sells
| 1 |
iShares Core S&P Small-Cap ETF
IJR
|
+$5.92M |
| 2 |
United States Antimony
UAMY
|
+$1.66M |
| 3 |
NVIDIA
NVDA
|
+$12.8K |
| 4 |
Cameco
CCJ
|
+$10.4K |
| 5 |
Corcept Therapeutics
CORT
|
+$9.82K |
Sector Composition
| 1 | Healthcare | 25.78% |
| 2 | Technology | 24.98% |
| 3 | Energy | 11.81% |
| 4 | Financials | 11.48% |
| 5 | Industrials | 8.43% |
Similar funds
GC
GCS
NI
CMANY
GMC
JCM
PCA
ACM
Tanaka Capital Management's Q4 2025 Portfolio in Review
As of Q4 2025, Tanaka Capital Management held 44 positions worth $54.8M, down 1.3% from $55.5M the previous quarter. Its ten largest holdings account for 67% of the portfolio.
Tanaka Capital Management withdrew a net $6.04M in Q4 2025, reducing 14 holdings. Its largest reduction was iShares Core S&P Small-Cap ETF, cutting an estimated $5.92M.
By sector, the portfolio is most concentrated in Healthcare at 26% of assets, up from 25% a quarter earlier, followed by Technology and Energy.
Against the trend, Tanaka Capital Management added an estimated $969K to Nuvation Bio.
- Tanaka Capital Management added most to Nuvation Bio in Q4 2025, an estimated $969K increase.
- Tanaka Capital Management's biggest Q4 2025 reduction was iShares Core S&P Small-Cap ETF, cutting an estimated $5.92M.
- Tanaka Capital Management's ten largest holdings make up 67% of its $54.8M portfolio in Q4 2025.
- Tanaka Capital Management opened 0 new positions and closed 0 in Q4 2025.
- Tanaka Capital Management's portfolio value fell 1.3% quarter-over-quarter to $54.8M.
Based on Tanaka Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.